Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Biocon, Tata Chemicals and financial stocks and advises selling Mindtree.
Ashwani Gujral of ashwanigujral.com recommends buying Ceat, Tata Motors DVR, Adani Ports and India Cements.
According to Ashwani Gujral of ashwanigujral.com, one should remain with Biocon and feels that Edelweiss Financial Services may hit Rs 135.
Rajat Bose of rajatkbose.com recommends buying HCL Tech, Biocon, Exide Industries, Hindalco Industries and Texmaco Rail and Engineering.
CIMB maintains add rating Infosys on reasonable valuations with target cut to Rs 1185 from Rs 1250 per share. It has cut FY17-19 EPs by 2-3 percent on client- specific issues and weakening macro. It remains optimistic on medium-to-long term.
Vishal Malkan of malkansview.com is of the view that one may buy Delta Corp with a target of Rs 170.
According to Mitesh Thacker of miteshthacker.com, one can buy Bajaj Finance, Biocon and LIC Housing Finance.
In an interview to CNBC-TV18, Sandeep S Shenoy of Pioneer Investcorp shared his readings and outlook on the market, specific stocks and sectors.
Rajat Bose of rajatkbose.com recommends buying Biocon and feels that Asian Paints and Pidilite Industries are multibaggers in the process.
Citi has a buy rating on ICICI Bank but reduced target to Rs 300 from Rs 315 per share. It says business/stock is getting closer to a turn and FY18 is likely to be better than FY17. It adds ICICI Bank‘s large, better-valued asset sales could protect profitability.
In an interview to CNBC-TV18 SP Tulsian of sptulsian.com shares why he feels Welspun India shares could hit lower circuit over next few trading sessions and why he prefers staying away from all the public sector units stocks like NTPC, Coal India, Engineers India, among others.
Rajat Bose of rajatkbose.com is of the view that one may prefer Biocon over Aurobindo Pharma.
Mitesh Thacker of miteshthacker.com is of the view that one can buy Biocon and Chambal Fertilisers and Chemicals.
In an interview to CNBC-TV18, Prakash Diwan of prakashdiwan.in shared his readings and outlook on specific stocks and sector.
Ashwani Gujral of ashwanigujral.com recommends buying Bajaj Finance, Biocon and Bharat Petroleum Corporation.
Ashwani Gujral of ashwanigujral.com recommends buying Biocon, Oriental Bank of Commerce and VIP Industries.
Ashwani Gujral of ashwanigujral.com recommends buying LIC Housing Finance, Punjab National Bank and Indraprastha Gas while he feels that Biocon may hit Rs 970.
Sharmila Joshi of sharmilajoshi.com is of the view that one may stay invested in pharma space with long term view.
Sanjiv Bhasin of IIFL recommends buying Dr Reddy's Labs, Cipla and Biocon.
Rahul Shah of Motilal Oswal recommends buying Indian Oil Corporation, JSW Steel and Biocon.
Prakash Gaba of prakashgaba.com likes DHFL and Tata Global Beverage and feels that Biocon may test Rs 1000.
Rajat Bose of rajatkbose.com feels that JK Tyre may test Rs 101 and Biocon Rs 845.
Rajat Bose of rajatkbose.com is of the view that Ashok Leyland looks weak for target of Rs 86 but recommends buying Biocon.
Prakash Gaba of prakashgaba.com is of the view that Ajanta Pharma can climb to around Rs 1800 and Biocon can climb to Rs 850.
Rajat Bose of rajatkbose.com is of the view that Sun Pharma is the best stocks in pharma space and feels that Biocon may hit Rs 845.